Medicare to Cover Dexcom G5 CGM System


The Centers for Medicare & Medicaid Services (CMS) has announced the determination of a benefit category and coverage for CGM.

In order to be included in this category, the system must be defined as a “therapeutic” CGM, meaning you can make treatment decisions using the device. The only CGM system that falls within this classification is Dexcom’s G5 CGM System, which received FDA approval for insulin dosing last month.

“This landmark CMS Ruling will make available the most important technology in diabetes management to the Medicare population,” said Kevin Sayer, Dexcom President and Chief Executive Officer. “We are pleased with this important step forward and we look forward to working with Medicare on implementing coverage in the coming months to ensure beneficiaries have access to this life-saving device.”

Medtronic’s CGM has not received FDA approval for dosing and therefore will not be included in this category and will not, at this time, be covered by Medicare.

Leave a Reply

1 Comment threads
1 Thread replies
Most reacted comment
Hottest comment thread
2 Comment authors
ChuckJanelle Recent comment authors
newest oldest most voted
Notify of

Does anyone know if this includes the Dexcom G4 with share CGM as well?


I spoke with Dexcom and they told me that only the G5 was approved. You have to purchase a G5 (at a subsidized price?) from Liberty Medical when everything is working. Go here for more info :

Copyright © 2009-2018 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.